Arab Finance: Macro Group Pharmaceutical (Macro Capital) recorded EGP 78.112 million in consolidated net losses attributable to the parent company during the first quarter (Q1) of 2024, compared to EGP 9.445 million in net profits in H1 2023, as per a filing.

Sales fell to EGP 59.536 million in Q1 2024 from EGP 155.201 million in Q1 2023.

Likewise, the company registered EGP 75.386 million in standalone net losses after tax in the three months to March, versus net profits of EGP 10.669 million in the same period last year.

Meanwhile, standalone sales went down to EGP 59.456 million from EGP 155.134 million.

Founded in 2002, Macro Group is a leading Egyptian cosmeceutical company based in Cairo.

Orascom Investment sees 4.9% YoY lower consolidated losses in 9 months Updated 12/31/2025 9:47:00 AM

Mohandes Insurance sees 4.86% YoY lower profits in 9 months Updated 12/31/2025 8:50:00 AM

ICON’s consolidated profits shrink 40% YoY in 9 months Updated 12/18/2025 10:55:00 AM

Maridive and Oil Services reports 105.5% YoY higher profits in 9 months Updated 12/14/2025 3:11:00 PM

Dice's consolidated profits fall 62.5% YoY in 9 months Updated 12/2/2025 11:15:00 AM